AWMT
PPH icon

AAFMAA Wealth Management & Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

AAFMAA Wealth Management & Trust’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
24,721
+1,212
+5% +$125K 0.94% 25
2026
Q1 		$2.44M Sell
23,509
-8,574
-27% -$913K 0.95% 23
2025
Q4 		$3.31M Sell
32,083
-7,917
-20% -$770K 1.3% 18
2025
Q3 		$3.61M Buy
40,000
+919
+2% +$80.5K 1.43% 14
2025
Q2 		$3.44M Sell
39,081
-2,875
-7% -$249K 1.42% 14
2025
Q1 		$3.82M Buy
41,956
+5,537
+15% +$499K 1.74% 11
2024
Q4 		$3.14M Buy
36,419
+1,100
+3% +$99.5K 1.38% 18
2024
Q3 		$3.36M Buy
35,319
+21,482
+155% +$2.04M 1.48% 18
2024
Q2 		$1.27M Buy
+13,837
New +$1.24M 0.62% 57

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
WF
Warner Financial Bethesda, Maryland $340M AUM 22.81% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
VIP
Value Investment Professionals New York $119M AUM
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return
CI
Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return
AT
Arlington Trust Birmingham, Alabama $1.18B AUM 11.55% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

AAFMAA Wealth Management & Trust's PPH Position: Q2 2026 in Review

AAFMAA Wealth Management & Trust increased its VanEck Pharmaceutical ETF (PPH) stake by 5.2% in Q2 2026, buying an estimated $125K and bringing the position to 24,721 shares worth $2.7M. The position accounts for 0.94% of the portfolio, ranked #25.

AAFMAA Wealth Management & Trust first reported a position in PPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.82M in Q1 2025. 13 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • AAFMAA Wealth Management & Trust held 24,721 shares of VanEck Pharmaceutical ETF worth $2.7M as of Q2 2026.
  • AAFMAA Wealth Management & Trust bought 1,212 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $125K.
  • VanEck Pharmaceutical ETF made up 0.94% of AAFMAA Wealth Management & Trust's portfolio in Q2 2026, its #25 holding.
  • AAFMAA Wealth Management & Trust first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 9 quarters since.
  • AAFMAA Wealth Management & Trust's VanEck Pharmaceutical ETF position peaked at $3.82M in Q1 2025.
  • 13 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on AAFMAA Wealth Management & Trust's 13F filing for Q2 2026, filed 8 Jul 2026.